Sleep is the one recovery tool nothing else compensates for.
A 2026 systematic review and meta-analysis in Lasers in Medical Science pooled five randomized controlled trials — 240 participants total — testing photobiomodulation against sham treatment for sleep quality, scored on the Pittsburgh Sleep Quality Index. The pooled result favored light therapy: a modest but statistically significant improvement (p = 0.03).
The detail worth sitting with: shorter protocols, four weeks or less, showed the consistent benefit. Longer courses did not add anything measurable on top of it.
The authors were direct about the limits. Every included trial carried a meaningful risk of bias. Sample sizes were small, confidence intervals were wide, and most studies leaned on self-reported sleep rather than objective measures like actigraphy. Their own conclusion: the effect "may not reach the threshold generally considered clinically meaningful."
What that means in practice — this is early-stage evidence, not a settled case. It points toward a real signal worth taking seriously, particularly around shorter, earlier-in-the-evening sessions rather than open-ended nightly use. It does not point toward light replacing the fundamentals: consistent sleep timing, darkness, temperature, and the rest of what actually moves sleep architecture.
Treat it as one input among several, not the mechanism carrying the outcome.
Individual response varies. This is general information, not medical advice. AIÓNMEN holds no medical clearance and makes no claim to treat, cure or prevent disease.
Source: Vital de Azevedo WM, de Souza K, Defante ML, Inoue Salgado AS, Lopes-Martins RÁB, Gomes da Silva S, Gonzalez-Lima F, dos Santos Cardoso F. "Photobiomodulation and sleep quality: systematic review and meta-analysis." Lasers in Medical Science, 2026.